Rolf M. Mesters

8.5k total citations
155 papers, 5.7k citations indexed

About

Rolf M. Mesters is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Rolf M. Mesters has authored 155 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Hematology, 55 papers in Oncology and 48 papers in Molecular Biology. Recurrent topics in Rolf M. Mesters's work include Blood Coagulation and Thrombosis Mechanisms (29 papers), Acute Myeloid Leukemia Research (29 papers) and Angiogenesis and VEGF in Cancer (26 papers). Rolf M. Mesters is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (29 papers), Acute Myeloid Leukemia Research (29 papers) and Angiogenesis and VEGF in Cancer (26 papers). Rolf M. Mesters collaborates with scholars based in Germany, United States and Switzerland. Rolf M. Mesters's co-authors include Wolfgang E. Berdel, Teresa Padró, Joachim Kienast, Ralf Bieker, Torsten Keßler, John H. Griffin, Christian Schwöppe, Martin Steins, Hubert Serve and Thomas Büchner and has published in prestigious journals such as Journal of Biological Chemistry, Nature Materials and Journal of Clinical Oncology.

In The Last Decade

Rolf M. Mesters

151 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rolf M. Mesters Germany 38 2.5k 2.2k 1.4k 729 651 155 5.7k
Marc A. Shuman United States 42 2.7k 1.1× 1.9k 0.9× 971 0.7× 1.6k 2.2× 1.1k 1.6× 83 6.5k
Giannoula Klement United States 29 847 0.3× 2.3k 1.1× 1.7k 1.2× 1.2k 1.6× 451 0.7× 67 4.9k
Vahid Afshar‐Kharghan United States 33 1.6k 0.7× 884 0.4× 1.1k 0.8× 428 0.6× 350 0.5× 89 4.1k
Daniel Kirchhofer United States 47 2.1k 0.8× 2.4k 1.1× 660 0.5× 667 0.9× 828 1.3× 116 6.4k
Nadia Carlesso United States 32 1.3k 0.5× 2.7k 1.3× 973 0.7× 468 0.6× 728 1.1× 65 5.5k
Andrea T. Hooper United States 32 1.1k 0.4× 2.8k 1.3× 2.6k 1.9× 1.2k 1.6× 689 1.1× 56 5.8k
John P. Chute United States 38 1.9k 0.8× 2.0k 0.9× 1.5k 1.1× 624 0.9× 865 1.3× 135 5.0k
Walter Fiedler Germany 45 3.9k 1.6× 5.0k 2.3× 2.7k 2.0× 1.2k 1.7× 1.8k 2.7× 299 9.5k
Barthel Barlogie United States 44 2.0k 0.8× 2.5k 1.2× 2.2k 1.6× 1.5k 2.1× 864 1.3× 121 7.0k
Francis Y. Lee United States 39 3.5k 1.4× 2.4k 1.1× 1.7k 1.3× 492 0.7× 2.6k 3.9× 103 7.4k

Countries citing papers authored by Rolf M. Mesters

Since Specialization
Citations

This map shows the geographic impact of Rolf M. Mesters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf M. Mesters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf M. Mesters more than expected).

Fields of papers citing papers by Rolf M. Mesters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf M. Mesters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf M. Mesters. The network helps show where Rolf M. Mesters may publish in the future.

Co-authorship network of co-authors of Rolf M. Mesters

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf M. Mesters. A scholar is included among the top collaborators of Rolf M. Mesters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf M. Mesters. Rolf M. Mesters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bacher, Ulrike, Cyrus Khandanpour, Phil‐Robin Tepasse, et al.. (2022). Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario. Cancers. 14(22). 5512–5512. 4 indexed citations
2.
Langenbruch, Lisa, Sven G. Meuth, Heinz Wiendl, Rolf M. Mesters, & Gabriel Möddel. (2020). Clinically relevant interaction of rivaroxaban and valproic acid – A case report. Seizure. 80. 46–47. 6 indexed citations
3.
Schliemann, Christoph, Andrea Kerkhoff, Jendrik Hardes, et al.. (2018). Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases. PLoS ONE. 13(5). e0197315–e0197315. 6 indexed citations
4.
Mesters, Rolf M., et al.. (2013). Plasma protein S residues 37–50 mediate its binding to factor Va and inhibition of blood coagulation. Thrombosis and Haemostasis. 110(8). 275–282. 7 indexed citations
5.
Goldenberg, Neil A., Gili Kenet, Fenella J. Kirkham, et al.. (2012). Role of reduced ADAMTS13 in arterial ischemic stroke: A Pediatric Cohort Study. Annals of Neurology. 73(1). 58–64. 39 indexed citations
6.
Park, Ji‐Ho, Kevin Lin, Neetu Singh, et al.. (2010). Nanoparticles that communicate in vivo to amplify tumour targeting. DSpace@MIT (Massachusetts Institute of Technology). 419 indexed citations
7.
Kreuter, Michael, Martin Kropff, Klaus Junker, et al.. (2009). Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment. European Respiratory Journal. 33(6). 1383–1388. 12 indexed citations
8.
Appelmann, Iris, Rüediger Liersch, Torsten Keßler, Rolf M. Mesters, & Wolfgang E. Berdel. (2009). Angiogenesis Inhibition in Cancer Therapy. Recent results in cancer research. 180. 51–81. 58 indexed citations
9.
Mormann, Michael, Johannes A. Eble, Christian Schwöppe, et al.. (2008). Fragmentation of intra-peptide and inter-peptide disulfide bonds of proteolytic peptides by nanoESI collision-induced dissociation. Analytical and Bioanalytical Chemistry. 392(5). 831–838. 52 indexed citations
10.
Mesters, Rolf M., Torsten Keßler, Christian Schwöppe, et al.. (2008). Generation of Fusion Proteins for Selective Occlusion of Tumor Vessels. Current Drug Discovery Technologies. 5(1). 1–8. 31 indexed citations
11.
Schliemann, Christoph, Ralf Bieker, Nils H. Thoennissen, et al.. (2007). Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia. 21(9). 1901–1906. 48 indexed citations
12.
Thoennissen, Nils H., Carsten Müller‐Tidow, Claudia Baumann, et al.. (2007). Heparin-Induced Thrombocytopenia vs. Plasmapheresis- Induced Platelet Loss in a Case of Thrombotic Thrombocytopenic Purpura. Transfusion Medicine and Hemotherapy. 34(1). 74–77.
13.
14.
Keßler, Torsten, Michael Möhr, Carsten Müller‐Tidow, et al.. (2007). Amsacrine containing induction therapy in elderly AML patients: Comparison to standard induction regimens in a matched-pair analysis. Leukemia Research. 32(3). 491–494. 9 indexed citations
15.
Bettendorf, Olaf, et al.. (2006). Neoplasia of the Kidney—a Rare Event During Pregnancy. European Urology. 50(1). 148–150. 4 indexed citations
16.
Kreuter, Michael, Ralf Bieker, Christoph Schliemann, et al.. (2006). Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia. 20(11). 1950–1954. 49 indexed citations
17.
Reinmuth, Niels, Ruth Wagner, Wolfgang E. Berdel, et al.. (2006). Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer. Lung Cancer. 55(1). 53–60. 18 indexed citations
18.
Yegneswaran, Subramanian, Rolf M. Mesters, José A. Fernández, & John H. Griffin. (2004). Prothrombin Residues 473–487 Contribute to Factor Va Binding in the Prothrombinase Complex. Journal of Biological Chemistry. 279(47). 49019–49025. 22 indexed citations
19.
Bieker, Ralf, Teresa Padró, Julia Krämer, et al.. (2003). Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.. PubMed. 63(21). 7241–6. 56 indexed citations
20.
Hoffmeier, A., M Semik, Christoph Schmid, et al.. (2002). Primäres Burkitt-Lymphom des Herzens – Diagnose und Therapie. Zeitschrift für Kardiologie. 91(4). 347–351. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc A. Shuman Breakdown of academic impact, for papers by Giannoula Klement Breakdown of academic impact, for papers by Vahid Afshar‐Kharghan Breakdown of academic impact, for papers by Daniel Kirchhofer Breakdown of academic impact, for papers by Nadia Carlesso Breakdown of academic impact, for papers by Andrea T. Hooper Breakdown of academic impact, for papers by John P. Chute Breakdown of academic impact, for papers by Walter Fiedler Breakdown of academic impact, for papers by Barthel Barlogie Breakdown of academic impact, for papers by Francis Y. Lee
Rankless by CCL
2026